Traumatic Brain Injury (TBI)
0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Baxter InternationalHemodynamic ABI Monitor
Oregon TherapeuticsAIM
Colorado Therapeuticsdivalproex sodium
Clinical Trials (3)
Total enrollment: 100 patients across 3 trials
Hemodynamic ABI Monitor
Start: Dec 2024Est. completion: Dec 202650 patients
N/ARecruiting
Attention Intervention Management
Start: Jan 2013Est. completion: Jan 20140
N/AWithdrawn
Valproate for Mood Swings and Alcohol Use Following Head Injury
Start: Sep 2008Est. completion: Jun 201650 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 100 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.